Smoking Cessation Study at Penn Open to Volunteers

This article has been archived.
Please use for reference only.

The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 26 de febrero del 2004

Share article


Imprima English

(February 26, 2004, Philadelphia, PA) - Researchers at the Abramson Cancer Center of the University of Pennsylvania are looking for volunteers to compare the effectiveness of two leading, FDA-approved smoking cessation medications in combination with different types of counseling. The study - led by clinical social worker Peter Gariti, PhD - is the world's first head-to-head trial of the two medications for light smokers. A previous study evaluated only heavy smokers.

Volunteers should be 18 years of age or older, in good health, smoke less than one pack a day and be motivated to stop smoking. Participants will be provided with nine weeks of medication plus up to 10 weeks of individual counseling. With time allowed for follow up, study participation is expected to last for nearly one full year. Study participants will receive the medication free of charge.

Researchers hope to recruit more than 260 participants for the study, which will remain open to volunteers for three and one-half years. Completion of the study is expected to take up to five years. The study is entirely supported through a funding grant from the National Institute on Drug Abuse, part of the National Institutes of Health.

Anyone interested should call 215-243-9959 for more information.

Contact: David March
(215) 615-3353

Imprima English
News
Study Links Text Messages and E-mails to Smoking Cessation

Apr 20, 2014 - While short-term text message mobile phone interventions have been effective, further research needs to be completed to determine whether messages sent over mobile phones can help individuals with smoking cessation over the long term, according to research published online Oct. 7 in the Cochrane Database of Systematic Reviews.



OncoLink Treatment Binder

Seleccione los efectos secundarios y formas de ligante de tratamiento de su paciente

Más información



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información